Lag-3 expression and clinical outcomes in metastatic melanoma patients treated with combination anti-lag-3 + anti-PD-1-based immunotherapies

por Gide, Tuba N., Paver, Elizabeth C., Yaseen, Zarwa, Maher, Nigel, Adegoke, Nurudeen, Menzies, Alexander M., Pires da Silva, Ines, Wilmott, James S., Long, Georgina V., Scolyer, Richard A.
Publicado 2023

Classification of the tumor immune microenvironment and associations with outcomes in patients with metastatic melanoma treated with immunotherapies

por Adegoke, Nurudeen A, Gide, Tuba N, Mao, Yizhe, Quek, Camelia, Patrick, Ellis, Carlino, Matteo S, Lo, Serigne N, Menzies, Alexander Maxwell, Pires da Silva, Ines, Vergara, Ismael A, Long, Georgina, Scolyer, Richard A, Wilmott, James S
Publicado 2023

Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome

por Attrill, Grace H., Lee, Hansol, Tasker, Annie T., Adegoke, Nurudeen A., Ferguson, Angela L., da Silva, Ines Pires, Saw, Robyn P. M., Thompson, John F., Palendira, Umaimainthan, Long, Georgina V., Ferguson, Peter M., Scolyer, Richard A., Wilmott, James S.
Publicado 2022

Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach

por Mao, Yizhe, Gide, Tuba N., Adegoke, Nurudeen A., Quek, Camelia, Maher, Nigel, Potter, Alison, Patrick, Ellis, Saw, Robyn P. M., Thompson, John F., Spillane, Andrew J., Shannon, Kerwin F., Carlino, Matteo S., Lo, Serigne N., Menzies, Alexander M., da Silva, Inês Pires, Long, Georgina V., Scolyer, Richard A., Wilmott, James S.
Publicado 2023